Livzon Pharmaceutical Group (SZSE:000513) Other Operating Expense : ¥414 Mil (TTM As of Mar. 2024)

View and export this data going back to 1993. Start your Free Trial

What is Livzon Pharmaceutical Group Other Operating Expense?

Livzon Pharmaceutical Group's Other Operating Expense for the three months ended in Mar. 2024 was ¥4 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 was ¥414 Mil.

Livzon Pharmaceutical Group's quarterly Other Operating Expense increased from Sep. 2023 (¥-199 Mil) to Dec. 2023 (¥412 Mil) but then declined from Dec. 2023 (¥412 Mil) to Mar. 2024 (¥4 Mil).

Livzon Pharmaceutical Group's annual Other Operating Expense increased from Dec. 2021 (¥352 Mil) to Dec. 2022 (¥456 Mil) but then declined from Dec. 2022 (¥456 Mil) to Dec. 2023 (¥408 Mil).

Livzon Pharmaceutical Group Other Operating Expense Historical Data

The historical data trend for Livzon Pharmaceutical Group's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Livzon Pharmaceutical Group Other Operating Expense Chart

Livzon Pharmaceutical Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Operating Expense

Get a 7-Day Free Trial

320.44

318.21

351.72

455.77

408.13

Livzon Pharmaceutical Group Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Operating Expense	Get a 7-Day Free Trial															-2.47	197.70	-199.42	412.32	3.65

Livzon Pharmaceutical Group Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥414 Mil.

Livzon Pharmaceutical Group Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Livzon Pharmaceutical Group's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Livzon Pharmaceutical Group (SZSE:000513) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Livzon Pharmaceutical Group Inc (SZSE:000513) » Definitions » Other Operating Expense

Traded in Other Exchanges

01513:Hong Kong LP6:Germany

Address

38 Chuangye North Road, Headquarters Building, Jinwan District, Guangdong Province, Zhuhai, CHN, 519090

Website

https://www.livzon.com.cn

Livzon Pharmaceutical Group Inc is engaged in China's healthcare sector. As a pharmaceutical manufacturer, the company's portfolio comprises Western pharmaceutical preparations, bulk drugs, traditional Chinese medicines, as well as diagnostic reagents and equipment. Its drug address serious conditions such as gastrointestinal, cardiovascular, anti-infectious, antimicrobial, antineoplastic, hemopoietic system, and other conditions. It distributes its products within domestic markets and to overseas markets. It operates in a single reportable segment which is pharmaceutical manufacturing.

Livzon Pharmaceutical Group (SZSE:000513) Headlines

No Headlines